No. 1 Story
ACCC clears Optus to scrap HFC network and use NBN instead
The ACCC has cleared, provisionally, the proposed deal between Optus and NBN Co under which Optus is to be paid around $800m to shut down its HFC network and transfer customers onto the NBN. read moreMore From
Ribarvirin shows promise in treating cancer patients
William Atkins
Thursday, 14 May 2009 18:04
Page 3 of 3
The researchers concluded in their abstract, “This first clinical study to target eIF4E in human malignancy demonstrates clinical activity and associated molecular responses in leukemic blasts.”
She states, "We also found that ribavirin not only blocks eIF4E, it has no side effect on patients." [EurekAlert]
Dr. Assouline adds, "We had striking clinical improvements with even partial and complete remissions.” [EurekAlert]
Dr. Borden concludes, "Combination therapy with chemotherapeutic agents may enhance the efficacy of this treatment. Trials in the near future are planned to overcome this and we are looking forward to more complete remissions." [EurekAlert]
"We also hope to test whether ribavirin is as effective in the treatment of other cancers with dysregulated eIF4E. Our laboratory studies suggest this is likely." [EurekAlert]
ClinicalTrials.gov reports on the study in the report “A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia (Borden-001).”
You think you have a disaster recovery plan?
Think again. Most businesses only have PART of a DR plan - and this spells business disaster in the event of an IT disaster.
Download The Seven Sins of Disaster Recovery White Paper now and find out how you can prevent this happening to you.
